Literature DB >> 27145811

Clarifying the best interests standard: the elaborative and enumerative strategies in public policy-making.

Chong-Ming Lim1, Michael C Dunn2, Jacqueline J Chin3.   

Abstract

One recurring criticism of the best interests standard concerns its vagueness, and thus the inadequate guidance it offers to care providers. The lack of an agreed definition of 'best interests', together with the fact that several suggested considerations adopted in legislation or professional guidelines for doctors do not obviously apply across different groups of persons, result in decisions being made in murky waters. In response, bioethicists have attempted to specify the best interests standard, to reduce the indeterminacy surrounding medical decisions. In this paper, we discuss the bioethicists' response in relation to the state's possible role in clarifying the best interests standard. We identify and characterise two clarificatory strategies employed by bioethicists -elaborative and enumerative-and argue that the state should adopt the latter. Beyond the practical difficulties of the former strategy, a state adoption of it would inevitably be prejudicial in a pluralistic society. Given the gravity of best interests decisions, and the delicate task of respecting citizens with different understandings of best interests, only the enumerative strategy is viable. We argue that this does not commit the state to silence in providing guidance to and supporting healthcare providers, nor does it facilitate the abuse of the vulnerable. Finally, we address two methodological worries about adopting this approach at the state level. The adoption of the enumerative strategy is not defeatist in attitude, nor does it eventually collapse into (a form of) the elaborative strategy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Competence/incompetence; Decision-making; Law; Political Philosophy; Public Policy

Mesh:

Year:  2016        PMID: 27145811     DOI: 10.1136/medethics-2016-103454

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  8 in total

1.  Post Gillick: Adolescent autonomy revisited: clinicians need clearer guidance.

Authors: 
Journal:  Br Dent J       Date:  2016-10-21       Impact factor: 1.626

2.  Best interest - but for whom?: Clarifying the best interests standard: the elaborative and enumerative strategies in public policy-making.

Authors: 
Journal:  Br Dent J       Date:  2016-09-23       Impact factor: 1.626

Review 3.  Making healthcare decisions in a person's best interests when they lack capacity: clinical guidance based on a review of evidence.

Authors:  Derick T Wade; Celia Kitzinger
Journal:  Clin Rehabil       Date:  2019-06-06       Impact factor: 3.477

4.  Forgoing life-sustaining treatment - a comparative analysis of regulations in Japan, Korea, Taiwan, and England.

Authors:  Miho Tanaka; Satoshi Kodama; Ilhak Lee; Richard Huxtable; Yicheng Chung
Journal:  BMC Med Ethics       Date:  2020-10-16       Impact factor: 2.652

Review 5.  Dialysis decisions concerning cognitively impaired adults: a scoping literature review.

Authors:  Jordan A Parsons; Jonathan Ives
Journal:  BMC Med Ethics       Date:  2021-03-05       Impact factor: 2.652

Review 6.  The theorisation of 'best interests' in bioethical accounts of decision-making.

Authors:  Giles Birchley
Journal:  BMC Med Ethics       Date:  2021-06-01       Impact factor: 2.652

7.  Dying too soon or living too long? Withdrawing treatment from patients with prolonged disorders of consciousness after Re Y.

Authors:  Richard Huxtable
Journal:  BMC Med Ethics       Date:  2019-12-30       Impact factor: 2.652

8.  Protocol for a scoping review to understand what is known about how GPs make decisions with, for and on behalf of patients who lack capacity.

Authors:  Simon Jack Ogden; Richard Huxtable; Jonathan Ives
Journal:  BMJ Open       Date:  2020-10-20       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.